Nirmita J. Patel

Inhibition of C-terminal binding protein attenuates transcription factor 4 signaling to selectively target colon cancer stem cells

Jagrut Patel, Somesh Baranwal, Ian M. Love et al. · Cell Cycle · 2014 · 73 citations · Full text

Chemoprevention Strategy, C-terminal Binding Protein, Selective Targeting +20

A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation

Rio S. Boothello, Nirmita J. Patel, Chetna Sharon et al. · Molecular Cancer Therapeutics · 2018 · 41 citations

Synthetic, Non-saccharide, Glycosaminoglycan Mimetics Selectively Target Colon Cancer Stem Cells

Nirmita J. Patel, Rajesh Karuturi, Rami A. Al‐Horani et al. · ACS Chemical Biology · 2014 · 41 citations · Full text

Cell-based Drug Delivery, Drug Targeting, Glycobiology +15

Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase

Nirmita J. Patel, Chetna Sharon, Somesh Baranwal et al. · Oncotarget · 2016 · 38 citations · Full text

Cancer Relapse.heparan Sulfate, P38 Map Kinase, Immunology +22

Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway<i>in vitro</i>and<i>in vivo</i>

Chetna Sharon, Somesh Baranwal, Nirmita J. Patel et al. · Oncotarget · 2015 · 28 citations · Full text